Zinc oxide nanoparticles (ZNPs) are extensively used in cosmetics and topical medications and are considered safe for normal skin. However, patients with inflammatory dermatoses, who have an impaired skin barrier, may be at increased risk of percutaneous exposure to ZNPs. Limited research currently exists on the percutaneous toxicity of ZNPs in such conditions. Therefore, this study aimed to evaluate the safety of ZNPs in inflammatory dermatoses. ZNP treatment increased inflammatory human immortalised keratinocyte (HaCaT) cell death and significantly elevated phosphorylated mixed lineage kinase domain-like protein (p-MLKL) protein expression in a concentration-dependent manner, showing that ZNPs trigger necroptosis in HaCaT cells. Further exploration revealed that ZNPs induced mitochondrial swelling and rupture and abnormal opening of the mitochondrial permeability transition pore (mPTP) in inflammatory HaCaT cells as well as decreased the expression of spastic paraplegia 7 (SPG7), a critical protein of the mPTP. Furthermore, phosphatidylserine decarboxylase (PISD) expression in the inner mitochondrial membrane (IMM) was significantly reduced. SPG7 overexpression reversed mPTP opening and necroptosis, whereas PISD overexpression directly upregulated SPG7 expression, inhibited mPTP opening, and reversed necroptosis. Our results indicate that ZNPs contribute to mPTP opening and mitochondrial swelling and rupture via the PISD/SPG7 pathway, an important mechanism leading to necroptosis in inflammatory HaCaT cells. Overall, this study highlights the potential hazards of ZNP exposure in patients with inflammatory dermatoses, reveals the mechanism of injury by which ZNPs induce skin toxicity, and provides data for future dermatotoxicological studies on ZNPs.
Evidence from cellular and animal model studies has shown that p,p-dichloro-diphenyl-trichloroethane (p,p'-DDT) and p,p-dichloro-diphenyl-dichloroethylene (p,p'-DDE) negatively affect the macrophage's inflammatory response and resistance to pathogen infections. Still, no evidence is available on the p,p'-DDE effects on human macrophages, even though there is a translational value to human public health. This study aimed to determine p,p'-DDE serum concentrations in human volunteers with non-occupational exposure and to investigate the effect of ex vivo exposure to p,p'-DDE on the polarization of human monocyte-derived macrophages (hMDM) toward the M1 phenotype. p,p'-DDE from thirty healthy male volunteers was quantified by gas chromatography with a micro-electron capture detector. The hMDM were differentiated using GM-CSF. hMDM were exposed to 25-2500 ng/ml p,p'-DDE for 48 h, and after 24 h of exposure, they were activated with LPS+IFN-γ to the M1 phenotype for 24 h. p,p ´ -DDT was detected in 4/30 individuals (mean= 0.54 ± 0.35 ng/ml), and 30/30 had p,p ´ -DDE (mean=0.57 ± 0.34 ng/ml). Ex vivo, p,p ´ -DDE did not affect cell viability but decreased the expression of M1-polarization markers (HLA-DR and CD68). Bivariate and multivariate analyses revealed that in the M1 macrophage phenotype, 25-2500 ng/ml p,p'-DDE, in a concentration-dependent manner, decreased NO•- -production, IL-1β, TNF-α, and IL-12 secretion, while increasing ROS. Our study showed that humans are still exposed to p,p'-DDE. Experimental results suggest that p,p'-DDE negatively interferes with the polarization of hMDMs toward the M1 phenotype at environmentally relevant concentrations, influencing key inflammatory mediators critical to innate immunity against pathogens and inducing oxidative stress. This study is the first to evaluate the effect of the p,p'-DDE on polarization of hMDMs to the M1-phenotype. It may contribute to addressing studies to determine whether the incidence of pathologies associated with inflammatory macrophage dysfunction is higher in human populations exposed to DDT and its metabolites. These data will be valuable for implementing policy and health intervention strategies in individuals still exposed to this pesticide.
Imidacloprid (IMI), a major neonicotinoid insecticide, raises concerns about neurodevelopmental abnormalities, particularly attention deficit hyperactivity disorder. However, the involvement of cerebellar development in IMI-induced developmental neurotoxicity has not been studied. Here, this study investigated the maternal exposure effects of IMI on the developing cerebellum in rats. Pregnant Sprague-Dawley rats were fed diet containing IMI at 0 (control), 83, 250 or 750 ppm from gestational day 6 through gestation, and dams treated with the diet during lactation until day 21 postpartum. Male offspring were raised without IMI until postnatal day 77. IMI exposure caused progressive changes of impaired motor coordination (≥ 250 ppm IMI groups) and loss of Purkinje cells (≥ 83 ppm) and granule cells (≥ 250 ppm). IMI suppressed granule cell proliferation by inhibiting sonic hedgehog-mediated cell cycle activation by downregulating Pcna, Cdk2, Shh, and Gli and promoted granule cell apoptosis by upregulating Casp3 during IMI exposure. Neuroinflammation and oxidative stress were key contributors to IMI-induced apoptosis in cerebellar neurons by downregulating Sod2 and upregulating Tnf. The obtained results suggest that exposure to even a lowest dose of IMI (83 ppm; 5.5-14.1 mg/kg/day) can lead to cerebellar defects in rat offspring.
Phthalates are typical environmental pollutants that, as plasticizers, are released into the environment through waste, accumulate in organisms, and have reproductive toxicity and potential carcinogenic risks. However, the specific regulatory mechanisms by which phthalates induce liver cancer are still unclear. This study investigates the role of CYP2C9 in liver cancer (LIHC) and its interaction with plasticizers such as BBP and DBP. Toxicological analyses reveal that CYP2C9 is significantly downregulated in LIHC, correlating with poorer patient survival rates. Differential expression analysis using TCGA and GTEx databases confirms high CYP2C9 expression in liver cells, negatively associated with immune cell infiltration. Methylation and mutation analyses indicate a significant relationship between CYP2C9 expression and methylation levels. Additionally, molecular dynamics simulations demonstrate strong binding stability between CYP2C9 and BBP. These findings underscore the critical role of CYP2C9 in liver cancer progression and support its potential as a therapeutic target.

